Thermo Fisher Scientific, Inc. (TMO) — Analysis Summary
Thermo Fisher Scientific, Inc. (TMO) has a market cap of $232.67B with year-over-year revenue growth of +3.9%. Net margin stands at 15.0%. The stock trades at a P/E ratio of 33.4.
Key Takeaways
- Revenue changed +3.9% year-over-year
- Net margin of 15.0%
- P/E ratio of 33.4
Compared to other companies in the MEASURING & CONTROLLING DEVICES, NEC sector, TMO posted revenue growth of +3.9% and trades at a P/E of 33.4.
Thermo Fisher Scientific, Inc. (TMO)
UPDATED — ET · MARKET DATA POLYGON · FINANCIALS SEC EDGAR
Red Flags & WarningsWatch List
Some caution signals are active and should be weighed alongside the valuation work.
Debt/EBITDA at 4.2x — elevated leverage
Operating margin (17.6%) exceeds gross margin (0.0%) — check for other operating income or data classification issues
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
Sector
MEASURING & CONTROLLING DEVICES, NEC
Employees
125,000
Headquarters
WALTHAM, MA
Exchange
XNYS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Annual Dividend/Share
$1.88
Dividend Yield
0.30%
Dividend History
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.